CCGA

Global Liquid Biopsy Markets, 2021-2025 with Q3 2021 Price and Volume Outlook Update - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 28, 2021
Health, Oncology, Breakout (video game), Cancer, Price, Diagnosis, Breast cancer, Customization, DNA, Exosome, Prognosis, COVID, Recurrence, Analysis, Technology, GRAIL, CCGA, Liquid biopsy, Menarini, Lung, Prostate, Treatment, Medical imaging, Vaccine

The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Price and Volume Outlook.

Key Points: 
  • The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Price and Volume Outlook.
  • The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report.
  • What is the impact of the COVID pandemic on the Liquid Biopsy market?
  • We look at Price and Volume Outlooks by type of cancer.

On-farm 4R Nutrient Stewardship Data Collection Continues to Expand with New Partners and Crops

Retrieved on: 
Monday, August 9, 2021
Technology, Environment, OFA, Adoption, CEO, CCGA, Farmer, Chair, GFO, Industry, Human, Knowledge, Flax, Nitrogen, Organization, Phosphorus, Awareness, Association, Research, Nutrient, Goal, Saskatchewan Wheat Pool, Agriculture

"The survey shows us how agri-retailers and farmers across Canada are implementing 4R Nutrient Stewardship, which is an approach that has been demonstrated to increase crop production while protecting our environment."

Key Points: 
  • "The survey shows us how agri-retailers and farmers across Canada are implementing 4R Nutrient Stewardship, which is an approach that has been demonstrated to increase crop production while protecting our environment."
  • Since 2014, the Fertilizer Use Survey has provided a credible source of information on fertilizer practices and trends across Canada.
  • The survey also examines the adoption of 4R Nutrient Stewardship related to crop type, region, soil practices, and farm size.
  • Additionally, the survey offers a comparison of science-based practices shown to reduce environmental impacts, comparing the adoption of 4R Nutrient Stewardship with crop performance and environmental stewardship.

Canadian Coast Guard Finishes Unique 2020 Arctic Operations Season

Retrieved on: 
Friday, December 11, 2020
Coast guards, Canadian Coast Guard, Canadian Coast Guard Auxiliary, CCGA, Yellowknife, Continents, Government of Canada, Safety, Arctic

YELLOWKNIFE, NT, Dec. 11, 2020 /CNW/ - The Canadian Coast Guard completed its 2020 Arctic operational season on December 1, 2020.

Key Points: 
  • YELLOWKNIFE, NT, Dec. 11, 2020 /CNW/ - The Canadian Coast Guard completed its 2020 Arctic operational season on December 1, 2020.
  • During the Arctic operational season, Coast Guard plays an integral role in the safety of both mariners and the environment.
  • Under the Oceans Protection Plan, Coast Guard is actively working with Indigenous and northern residents to support the Canadian Coast Guard Auxiliary (CCGA) across the Arctic.
  • They will resume again in May 2021, however Coast Guard maintains a permanent, full-time presence in the Arctic year-round, with the opening of the Canadian Coast Guard office in Yellowknife.

GRAIL to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting

Retrieved on: 
Monday, April 27, 2020
Oncology, Health, Clinical trials, Research, Science, Biotechnology, RTT, Cancer, CCGA, GRAIL’s Multi-Cancer Early Detection Test, GRAIL

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.

Key Points: 
  • GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.
  • These new data evaluate the performance of GRAIL's test in symptomatic participants with suspicion of cancer.
  • This technology could be particularly useful in directing a more efficient diagnostic workup in symptomatic patients who are being evaluated for cancer.
  • GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early.

GRAIL Announces Validation of Its Multi-Cancer Early Detection Test Published in Annals of Oncology

Retrieved on: 
Tuesday, March 31, 2020
Research, Publishing, Genetics, Clinical trials, Communications, Biotechnology, Health, Science, Oncology, Other Science, RTT, Cancer screening, Medicine, Cancer, Clinical medicine, Prostate cancer, Oncology, Overdiagnosis, CCGA, GRAIL’s Multi-Cancer Early Detection Test, GRAIL

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced validation data for its multi-cancer early detection blood test were published in Annals of Oncology .

Key Points: 
  • GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced validation data for its multi-cancer early detection blood test were published in Annals of Oncology .
  • These findings support the potential significant public health benefit of an accurate and highly specific multi-cancer early detection test.
  • GRAILs multi-cancer early detection test is designed to detect cancers in early stages, when the chance of survival is higher than if cancer is detected after symptoms appear.
  • GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured.

GRAIL Announces Positive Validation Data for Its Multi-Cancer Early Detection Test

Retrieved on: 
Monday, October 7, 2019
Medical devices, Genetics, Clinical trials, Biotechnology, Pharmaceutical, Health, Oncology, RTT, Cancer, Grails, Biology, Molecular biology, Life sciences, Medical genetics, Biotechnology, Medical devices, Genetics, Clinical trials, Biotechnology, Pharmaceutical, Health, Oncology, RTT, Cancer, Grails, Biology, Molecular biology, Life sciences, Medical genetics, Biotechnology, CCGA, GRAIL’s Investigational Multi-Cancer Early Detection Test, GRAIL

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced new data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants.

Key Points: 
  • GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced new data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants.
  • GRAILs large-scale clinical study program is designed to train and develop a multi-cancer early detection test, as well as validate its performance.
  • Performance in the validation analysis was consistent with previously reported results from data used to train GRAILs cancer detection algorithm to classify cancer and non-cancer signals.
  • GRAIL is developing a next-generation sequencing (NGS) blood test for the early detection of multiple deadly cancer types.

PelicanCorp to Attend Canadian Common Ground Alliance Damage Prevention Symposium

Retrieved on: 
Monday, October 7, 2019
CCGA

MELBOURNE, Australia, Oct. 7, 2019 /PRNewswire/ -- PelicanCorp, the leading provider of damage prevention software and services to the Canadian One Call industry, is pleased to attend the 2019 Canadian Common Ground Alliance's (CCGA) Annual Damage Prevention Symposium .

Key Points: 
  • MELBOURNE, Australia, Oct. 7, 2019 /PRNewswire/ -- PelicanCorp, the leading provider of damage prevention software and services to the Canadian One Call industry, is pleased to attend the 2019 Canadian Common Ground Alliance's (CCGA) Annual Damage Prevention Symposium .
  • The CCGA provides a unified damage prevention voice and attracts members from all Canadian national organizations and associations who share a common interest in damage prevention and public safety.
  • The Symposium, this year being held in Niagara Falls, Ontario, from Oct. 8-10, 2019, focuses on critical damage prevention issues and solutions specific to Canadian stakeholders.
  • PelicanCorp will be demonstrating their leading cloud-based damage prevention platform, currently being integrated throughout One Call centers located across Canada.